ReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Call
28 mars 2023 21h50 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that...
ReShape Lifesciences Announces Formation of International Scientific Advisory Board
23 mars 2023 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the...
ReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update
22 mars 2023 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that...
ReShape Lifesciences® to Present at the Q2 Virtual Investor Summit
15 mars 2023 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
ReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public Offering
08 févr. 2023 12h07 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the...
ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering
06 févr. 2023 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the...
ReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022
22 déc. 2022 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update
14 nov. 2022 07h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported...
ReShape Lifesciences Announces $750,000 Registered Direct Offering
08 nov. 2022 09h28 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
ReShape Lifesciences™ to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update
07 nov. 2022 13h22 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that...